Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Financial goals should evolve with life. This guide covers indicators that warrant updating targets and practical steps to realign your plan.
22,496 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
SpaceX is set to begin trading after a record $75 billion IPO, signaling strong appetite for space-enabled growth. Ma...
Retirees may secure a steadier paycheck by starting small and letting dividend growth drive long‑term income.
The Supreme Court struck down key tariffs under IEEPA, but the administration is weighing strategies to preserve the ...
Retirees with a $500,000 portfolio face a choice between dividend-driven income and the traditional 4% rule. Early da...
Vanguard's dividend-growth ETF outpaced the Dividend Aristocrats ETF over the past decade, delivering higher returns ...
Rivian just raised its vehicle guidance to 70,000 units while a company director sold shares. This article breaks dow...
Geopolitical tension over Iran raises the risk of a prolonged strait hormuz closure, with analysts warning it could l...
When top executives trim stakes, investors take note. This article breaks down the meaning behind such moves, with a ...
Investors now have dedicated ETFs to take sides on the Magnificent Seven debate, including concentrated exposure via ...
GhostSwap launches a no-onboarding swap experience that lets users exchange 1,600+ tokens in minutes, without email, ...
As Archer Aviation moves toward broader commercial programs, investors need a clear view of 2025 earnings drivers. Th...